Fluvoxamine maleate extended-release
NDC 70710-1847, Fluvoxamine maleate extended-release, capsule, extended release, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-1847
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220447
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1847 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLUVOXAMINE MALEATE100 mg/1
Pharmacologic classes
Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1847-3 | 70710184703 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70710-1847-3) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6c71d4f6-54b5-4d3a-8d2f-b7773c92c32eNADAC price for package 70710184703
GET /v1/drugs/nadac/70710184703
Use it
Look up 70710-1847 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1847 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1847. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.